side effects glp 1 agonist Adverse of GLP-1 Receptor Agonists Exploring the Side Effects of

Using a projected Target Scan algorithm, miR-27a may target the PPAR gene

Excess abdominal fat is associated with higher inflammation and increased risk of insulin resistance, high blood pressure, and cardiovascular disease, which is why many menopausal women consider GLP-1 medications as part of a broader, clinician-guided weight management plan

The GLP-1 RAs were originally developed for the treatment of type 2 diabetes mellitus (T2DM), but they soon showed promising effects in weight reduction [1, 2]

doi:10.2337/db13-1688 11

Nov 2023 - The FDA's approval of Eli Lillys Zepbound (tirzepatide) represents a significant advancement in obesity treatment, as it uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors